22nd Century Group, Inc. XXII

Company Overview

22nd Century Group, Inc. is a U.S.-based biotechnology and agricultural company focused on reduced nicotine tobacco products, hemp/cannabis research, and plant science innovation. The company has historically operated at the intersection of biotechnology and consumer packaged goods, using proprietary genetic engineering and plant breeding technologies to modify nicotine content in tobacco plants and cannabinoid profiles in cannabis and hemp plants. Its primary industries include tobacco products, agricultural biotechnology, and consumer health-oriented nicotine products.

The company’s core revenue drivers have included sales of combustible cigarette products with reduced nicotine content, contract manufacturing services, and licensing or development activities tied to its proprietary plant genetics technologies. A central component of its strategy has been the commercialization of very low nicotine content (VLNC) cigarettes designed to align with evolving public health and regulatory trends. 22nd Century Group was founded in 1998 and evolved from a plant biotechnology research company into a commercial-stage business focused on tobacco harm reduction and specialty agricultural products. The company has positioned itself as a niche innovator in the regulated tobacco market through intellectual property related to nicotine biosynthesis and tobacco genetics.